Site-Specific Factor 3
International Prognostic Index (IPI)
Notes
**Note 1:** The International Prognostic Index ( IPI) has been developed for lymphomas and predicts outcome based on the following adverse factors * Age more than 60 years * Ann Arbor Stage III or IV * More than 1 extranodal site involved * Patient's performance status (Eastern Cooperative Oncology Group, ECOG) 2, 3, or 4 * Elevated serum lactate dehydrogenase (LDH) level **Note 2:** Record the IPI as stated in the medical record. Do not calculate points or assign risk. Only record points or risk if a physician has documented them. Use points over risk if both are available. **Note 3:** There are now two indices/scores associated with lymphoma * The International Prognostic Index (IPI) (**Site-Specific Factor 3**) * The Follicular Lymphoma International Prognostic Index (FLIPI) (**Site-Specific Factor 4**). Physicians may use these indices/scores interchangeably. For coding * Score identified: Value in appropriate SSF, 999 in other SSF * Score not identified, point value 5 or less: 999 in both SSFDefault
988NAACCR Item
NAACCR #2900Metadata
None| Code | Description |
|---|---|
| 000 | 0 points |
| 001 | 1 point |
| 002 | 2 points |
| 003 | 3 points |
| 004 | 4 points |
| 005 | 5 points |
| 988 | Not applicable: Information not collected for this case |
| 990 | Stated as low risk (0-1 point) |
| 991 | Stated as low intermediate risk (2 points) |
| 992 | Stated as intermediate risk (3 points) |
| 993 | Stated as high risk (4-5 points) |
| 999 | Unknown or no information Not documented in patient record |